KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Shares Issued (2016 - 2025)

Resmed (RMD) has disclosed Shares Issued for 17 consecutive years, with $29.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued rose 9.97% year-over-year to $29.6 million, compared with a TTM value of $76.9 million through Dec 2025, up 13.4%, and an annual FY2025 reading of $74.4 million, up 40.2% over the prior year.
  • Shares Issued was $29.6 million for Q4 2025 at Resmed, up from $8.2 million in the prior quarter.
  • Across five years, Shares Issued topped out at $30.2 million in Q2 2025 and bottomed at $145000.0 in Q1 2021.
  • Average Shares Issued over 5 years is $14.0 million, with a median of $14.0 million recorded in 2021.
  • The sharpest move saw Shares Issued plummeted 92.01% in 2021, then soared 1840.69% in 2022.
  • Year by year, Shares Issued stood at $19.1 million in 2021, then increased by 15.47% to $22.1 million in 2022, then dropped by 11.48% to $19.5 million in 2023, then skyrocketed by 37.66% to $26.9 million in 2024, then rose by 9.97% to $29.6 million in 2025.
  • Business Quant data shows Shares Issued for RMD at $29.6 million in Q4 2025, $8.2 million in Q3 2025, and $30.2 million in Q2 2025.